The Jan and Dan Duncan Neurological Institute is home to 37 Principal Investigators, more than 400+ scientists and 10 Core labs.
Dan and Duncan Neurological Institute also house the Gordon and Mary Cain Pediatric Neurology Research Foundation Laboratories which are focused on epilepsy research and Baylor College's of Medicine's Center for Drug Discovery which is aimed at quick identification and advancement of small molecules to clinical trials.
Since inception, more than 1700 scientific studies have been published, and more than 85 disease-causing genetic mutations have been discovered or co-discovered by our scientists. There are currently 6 active clinical trials and studies.
Submissions from 2022
Functional Studies of Genetic Variants Associated with Human Diseases in Notch Signaling-Related Genes Using Drosophila, Sheng-An Yang, Jose L Salazar, David Li-Kroeger, et al.
In Alzheimer-Prone Brain Regions, Metabolism and Risk-Gene Expression Are Strongly Correlated, Fengdan Ye, Quentin Funk, Elijah Rockers, et al.
Sequencing Individual Genomes With Recurrent Genomic Disorder Deletions: An Approach To Characterize Genes for Autosomal Recessive Rare Disease Traits, Bo Yuan, Katharina V Schulze, Nurit Assia Batzir, et al.
Parental Mosaicism for Apparent De Novo Genetic Variants: Scope, Detection, and Counseling Challenges, Roni Zemet, Ignatia B Van den Veyver, and Paweł Stankiewicz
Disruption of MeCP2-TCF20 Complex Underlies Distinct Neurodevelopmental Disorders, Jian Zhou, Hamdan Hamdan, Hari Krishna Yalamanchili, et al.
Propranolol Modulates Cerebellar Circuit Activity and Reduces Tremor., Joy Zhou, Meike E Van der Heijden, Luis E Salazar Leon, et al.
Submissions from 2021
Cerebellar Coordination of Neuronal Communication in Cerebral Cortex, Samuel S McAfee, Yu Liu, Roy V Sillitoe, et al.